mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.03 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.03 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.03 |